ProfileGDS4718 / 219122_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 78% 68% 78% 74% 69% 82% 88% 76% 72% 76% 79% 71% 81% 79% 86% 83% 81% 78% 90% 68% 76% 75% 78% 79% 78% 79% 74% 82% 78% 85% 83% 84% 60% 77% 92% 88% 87% 77% 73% 75% 77% 82% 81% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.6344478
GSM549102patient 115, normal, homogenized [OPG study]6.7258768
GSM549104patient 119, normal, homogenized [OPG study]7.6678578
GSM549108patient 138, normal, homogenized [OPG study]7.1285574
GSM549119patient 077, normal, homogenized [OPG study]6.7879369
GSM549133patient 032, cancer, homogenized [OPG study]8.2707482
GSM549139patient 042, cancer, homogenized [OPG study]8.8596888
GSM549099patient 107, normal, homogenized [OPG study]7.3532776
GSM549109patient 139, normal, homogenized [OPG study]6.9882472
GSM549110patient 046, normal, homogenized [OPG study]7.3554476
GSM549114patient 063, normal, homogenized [OPG study]7.7709279
GSM549122patient 082, normal, homogenized [OPG study]6.9655371
GSM549134patient 033, cancer, homogenized [OPG study]7.9628781
GSM549136patient 036, cancer, homogenized [OPG study]7.8227779
GSM549140patient 044, cancer, homogenized [OPG study]8.636286
GSM549111patient 047, normal, homogenized [OPG study]8.3182883
GSM549113patient 057, normal, homogenized [OPG study]8.0826581
GSM549132patient 031, cancer, homogenized [OPG study]7.6444178
GSM549137patient 038, cancer, homogenized [OPG study]9.0934690
GSM549142patient 047, cancer, homogenized [OPG study]6.7414768
GSM549100patient 110, normal, homogenized [OPG study]7.3142276
GSM549107patient 135, normal, homogenized [OPG study]7.3040675
GSM549115patient 068, normal, homogenized [OPG study]7.6790778
GSM549116patient 072, normal, homogenized [OPG study]7.7995179
GSM549120patient 078, normal, homogenized [OPG study]7.5805478
GSM549131patient 030, cancer, homogenized [OPG study]7.8139679
GSM549118patient 074, normal, homogenized [OPG study]7.2275674
GSM549129patient 027, cancer, homogenized [OPG study]8.1297682
GSM549123patient 088, normal, homogenized [OPG study]7.6784278
GSM549124patient 006, cancer, homogenized [OPG study]8.3802985
GSM549126patient 015, cancer, homogenized [OPG study]8.157983
GSM549128patient 025, cancer, homogenized [OPG study]8.4496284
GSM549103patient 117, normal, homogenized [OPG study]6.1345560
GSM549117patient 073, normal, homogenized [OPG study]7.4959977
GSM549138patient 041, cancer, homogenized [OPG study]9.5327592
GSM549141patient 045, cancer, homogenized [OPG study]8.9169388
GSM549130patient 028, cancer, homogenized [OPG study]8.7226487
GSM549101patient 111, normal, homogenized [OPG study]7.5174777
GSM549105patient 128, normal, homogenized [OPG study]7.143673
GSM549106patient 134, normal, homogenized [OPG study]7.4984175
GSM549112patient 048, normal, homogenized [OPG study]7.5542277
GSM549125patient 011, cancer, homogenized [OPG study]8.0618282
GSM549127patient 024, cancer, homogenized [OPG study]8.0384681
GSM549135patient 035, cancer, homogenized [OPG study]8.5475385